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Autographa californicaChondroitin lyases have been known as pathogenic bacterial enzymes that degrade chondroitin.
Recently, baculovirus envelope protein ODV-E66 was identiﬁed as the ﬁrst reported viral chondroi-
tin lyase. ODV-E66 has low sequence identity with bacterial lyases at <12%, and unique characteris-
tics reﬂecting the life cycle of baculovirus. To understand ODV-E66’s structural basis, the crystal
structure was determined and it was found that the structural fold resembled that of polysaccharide
lyase 8 proteins and that the catalytic residues were also conserved. This structure enabled discus-
sion of the unique substrate speciﬁcity and the stability of ODV-E66 as well as the host speciﬁcity of
baculovirus.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Chondroitin, a sulfated glycosaminoglycan, exists as a compo-
nent of extracellular matrix polysaccharides, which play an impor-
tant role in cell-to-cell associations [1]. Chondroitin is a linear
polysaccharide consisting of [–4-D-glucronic acid (GlcUA)-b-1-3-
N-acetyl-D-galactosamine (GalNAc) b1–]n repeating disaccharide
units and is frequently sulfated at the C-4 or C-6 positions of the
GalNAc residue or at the C-2 position of the GlcUA residue [2,3],
named chondroitin 4-sulfate, chondroitin 6-sulfate, and dermatan
sulfate, respectively (also chondroitin sulfate A, C, and B,
respectively).
Three main kinds of chondroitin lyases have been identiﬁed
that can degrade chondroitin [4,5]. Chondroitin AC lyase can
degrade non-sulfated chondroitin and chondroitin sulfates A and
C. Chondroitin B lyase can degrade chondroitin sulfate B, while
chondroitin ABC lyase can degrade all the above-mentioned
chondroitins. These lyases are derived from pathogenic bacteria,making it possible for these bacteria to access a target cell by
degrading the chondroitin in its extracellular matrix [6]. Recently,
such enzymes have been studied as possible therapeutic tools for
dealing with infections and/or neural regeneration [6–8].
We have previously reported an occlusion-derived virus enve-
lope protein 66 (ODV-E66) from Autographa californica, a kind of
baculovirus, as a novel chondroitin lyase in virus [9]. ODV-E66
has unique characteristics closely related to the baculovirus life
cycle, being released in an insect’s midgut after feeding on baculo-
virus and degrading the host cells’ extracellular matrix to gain
access to the cells. ODV-E66 is quite stable and retains its enzy-
matic activity over a wide pH range (pH 4–9) and temperature
(30–60 C). This character reﬂects that baculovirus exists in the
ﬁeld, awaiting ingestion by an insect. In addition, ODV-E66 has un-
ique substrate speciﬁcities, only able to degrade non-sulfated
chondroitin and chondroitin sulfate C, making it similar in this
respect to chondroitin AC lyase, except for the latter’s ability to
degrade chondroitin sulfate A. This narrower range of substrate
speciﬁcity might reﬂect the baculovirus’s host speciﬁcity. Baculovi-
rus infects lepidopteran insect larvae midgut cells whose extracel-
lular matrix, the peritrophic membrane, contains low proportions
of chondroitin sulfate A [10–13]. Previous reports have shown that
an odv-e66 gene is essential for baculovirus oral infection [14] and
that the N-terminus region of ODV-E66 has an afﬁnity for midgut
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gest the importance of ODV-E66 to infectivity of baculovirus which
is now widely used as a protein expression system [16,17]. To
understand the relationship between these unique characteristics
of ODV-E66 and its structural information, the crystal structure
was determined. The structural information enables to discuss
the unique substrate speciﬁcity and the stability of ODV-E66, and
the host speciﬁcity of baculovirus.
2. Materials and methods
2.1. Preparation of native ODV-E66 crystal and X-ray data collection
Procedures for expression, puriﬁcation, crystallization, and
X-ray data collection of recombinant ODV-E66 was performed as
previously reported [9,18]. In this study, ODV-E66 (67–704) is
described as only ‘ODV-E66’.
2.2. Preparation of iodine derivative ODV-E66 crystal
A ODV-E66 crystal was soaked for 30 s in a pH 8.8 buffer,
comprising 15% glycerol (v/v), 50 mM Tri-HCl, 100 mM NaCl,
0.02 M citric acid, 0.08 M Bis–Tris propane, 18% PEG3350 (w/v),
and 1 M iodine potassium, and then ﬂash-cooled in nitrogen-gas
cryostream (Rigaku Corp., Tokyo, Japan) at 180 C. All intensity
data were indexed, integrated, and scaled with the HKL-2000 soft-
ware package [19]. Data collection statistics of native and iodine
derivative ODV-E66 are summarized in Table 1.
2.3. Structure determination and reﬁnement
The initial phase of ODV-E66 structural determination was per-
formed using the iodine derivative data with single isomorphous
replacement and an anomalous scattering (SIRAS)-method by theTable 1
Data collection and reﬁnement statistics.
Data collection Native Iodine derivative
Space group P62 P62
Unit cell parameters a = b = 113.5 Å,
c = 101.5 Å
a = b = 118.2 Å,
c = 100.1 Å
Wavelength (Å) 1.3 1.3
No. of reﬂections
Observed/unique 791385/68227 550152/146886
Redundancy 8.1 (7.9) 5.4 (5.3)
Rsym 0.094 (0.901) 0.135 (0.714)
I/r (I) 25.26 (1.86) 28.13 (3.80)
Completeness (%) 100.0 (100.0) 98.4 (96.8)
Reﬁnement statistics
Resolution range (Å) 35.31–2.00 8.74–2.00
No. of reﬂections
Working set/test set 47690/2484 67619/3554
Completeness (%) 99.95 97.84
Rcryst (%)/Rfree (%) 17.35/20.64 16.78/19.42
Root mean square deviation
Bond length (Å) 0.006 0.0006
Bond angles () 1.073 1.046
Average B-factor (Å2)/No. of atoms
Protein 43.7/5094 32.2/5030
Water 29.4/615 22.2/606
Glycerol 73.4/12 47.6/48
Iodine 26.3/76
Ramachandran analysis
Favored (%) 95.2 95.9
Allowed (%) 4.4 4.1
Outlier (%) 0.3 0.0
PDB ID 3VSM 3VSNHKL2MAP software package [20]. The partial mode was built auto-
matically using ARP/wARP [21] and modiﬁed manually using COOT
[22]. The structure was revised several times by alternately adjust-
ing the model and reﬁnements using Refmac [23]. The structure of
ODV-E66 without iodine was solved by molecular replacement
using the iodine derivative ODV-E66 coordinates as a search model
and the programMOLREP [24]. The structure was then revised sev-
eral times by alternately adjusting the model and reﬁnements
using COOT and Refmac. The resulting two structures were called
native and iodine derivative ODV-E66; the reﬁnement statistics
are summarized in Table 1. Stereochemical checks were carried
out using Molprobity [25]. The atomic coordinates and structural
factors of the native and iodine derivative protein have been
deposited in the Protein Data Bank at Rutgers University under
accession code 3VSM and 3VSN, respectively. Each ﬁgure was de-
scribed using PYMOL program (Fig. 1 and Suppl. Fig. 2a).
2.4. Mutational analysis
Bacterial pET15b vectors harboring the ODV-E66 mutants,
N236A, H291A, Y299F, R345A, and E395A were prepared using
the PCR-based Takara PrimeSTAR mutagenesis kit (Takara Bio,
Inc., Otsu, Japan), with pET15b-ODV-E66 as the template; primer
sequences are shown in Supplementary Table 1. The PCR-ampliﬁed
pET15b-ODV-E66 mutant constructs were sequenced to conﬁrm
the anticipated mutations using the services of Operon Biotechnol-
ogies (Huntsville, AL, USA). Both ODV-E66 wild type and mutants
for mutational analysis were expressed and puriﬁed as previously
reported [9,18]. The assay for measuring enzymatic activity is de-
scribed as a Supplementary Method.
3. Results and discussion
The crystal structures of native and iodine derivatized ODV-
E66 were determined at 2.0 Å resolution. In the native ODV-E66
(PDB ID: 3VSM), a total of 632 of 638 residues (67–704) were
modeled and 615 water molecules found to be incorporated. In
the iodine derivative ODV-E66 (PDB ID: 3VSN), a total of 631 of
638 residues were modeled, and 606 water molecules and 76 io-
dine ions were incorporated. As the r.m.s.d. value between native
and iodine derivative ODV-E66 was 0.88 Å from 631 Cas, the two
structures resembled each other. The overall structure of native
ODV-E66 conﬁrmed the protein to be composed of two domains,
an a-helix rich domain in the N-terminus side and a b-strand rich
domain in the C-terminus side (Fig. 1). The a-helix rich domain
contained eight a-helices and four short b-strands with 202 res-
idues of amino acids forming an a/a troid topology, whereas
the b-strand rich domain contained 31 b-strands and 12
short a-helices with 431 amino acids forming an anti-parallel
b-sandwich. These structural features were very similar to the
well-characterized polysaccharide lyase 8 (PL8) family enzymes,
which includes chondroitin AC lyase (cAC lyase) and chondroitin
ABC lyase (cABC lyase) [6], although the amino acid sequence
identities were <12%. The results of a VAST search [26] showed
cAC lyase from Pedobacterium heparinum (Flavobacterium hepari-
num) [27] to have the highest score, at 41.5. The structural
features of PL8 family enzymes are well deﬁned [6,28], including
the formation of an (a/a)5,6 troid domain in the N-terminus
side and a b-sandwich domain in the C-terminus side, and corre-
sponded well with that of ODV-E66.
PL8 family enzymes are known as pathogenic, bacterial, poly-
saccharide lyases, which are capable of degrading on polysaccha-
rides in the extracellular matrix of host tissues and to contribute
to their invasive abilities [29]. These enzymes recognize substrate
polysaccharide between the a/a troid and b-sandwich domains.
Then, they catalyze a b-elimination reaction that results in
Fig. 1. Overall structure of ODV-E66. Crystal structure of ODV-E66 (PDB ID: 3VSM) described as a cartoon mode. Right ﬁgure indicates 90-turn around vertical axle of left
ﬁgure structure; N, N-terminus and C, C-terminus of ODV-E66; a/a troid domain, orange; and b-sandwich domain, light orange.
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forming a new reducing end and an unsaturated sugar at the
non-reducing end. This catalytic reaction is performed by ﬁve
catalytic residues, with Asn or Asp as a neutralizer for the car-
boxyl group in substrate uronic acid and His, Tyr, Arg, and Glu
as catalytic bases/acids [28].
The structural alignment, based on structural information of
ODV-E66 and structurally characterized PL8 proteins [27,30–33]
using the MATRAS program [34], is described in Fig. 2. According
to this alignment, ODV-E66 possessed all ﬁve residues correspond-
ing to the catalytic residues in PL8, as Asn236, His291, Tyr299,
Arg345, and Glu395 (Fig. 2). Notably, a mutational analysis showed
that the mutated ODV-E66 forms N236A, H291A, Y299F, R345A,
and E395A lose their chondroitin degrading activity, suggesting
that these ﬁve residues were indeed essential for catalysis (Suppl.
Fig. 1).
For these residues to be regarded as catalytic residues, an inter-
domain movement should occur between the aa troid and b-sand-
wich domains. This should occur because the distances between
Asn236 in the aa troid domain and the other four putative cata-
lytic residues existing in the b-sandwich domain was 5 Å longer
than other PL8 family’s corresponding residues when they exert
their activity. In the PL8 family, interdomain movements con-
trolled by substrate binding have been observed in hyaluronate
lyases derived from Streptomyces coelicolor A3(2), Streptococcus
pneumonia, and Streptococcus agalactiae [30,35–37]. In addition, a
slight interdomain difference in position was observed between
native and iodine-derivatized ODV-E66 crystal structures (Suppl.Fig. 2. Selected sequence alignment of ODV-E66 based on structural information. Mu
categorized into PL8, described using MATRAS program. Selected sequence, position of k
ODV-E66; numbers along alignment, amino acid number of ODV-E66; aligned residues, w
positioned at interaction with sulfate group of chondroitin sulfate. The pdb code in ﬁ
heparinum; 1rw9, chondroitin AC lyase derived from Arthrobacter aurescens; 2wda, hyalu
derived from Proteus vulgaris; and 2q1f, chondroitin ABC lyase derived from BacteroidesFig. 2). Thus, ODV-E66 should move between domains to exert
its activity.
Considering the enzyme’s movement, an active model of ODV-
E66 was constructed and the putative catalytic residues deter-
mined to be indeed catalytic residues (Fig. 3a). The model was
formed by superposing ODV-E66 on a cAC lyase derived from P.
heparinum [38], with the a/a troid and b-sandwich domains sepa-
rated. The model was constructed by superimposing all atoms of
Asn236 in ODV-E66 and Asn175 in cAC lyase, while His291,
Tyr299, Arg345, and Glu395 in ODV-E66 were superposed on
His225, Tyr234, Arg288, and Glu371 in cAC lyase. In this model,
Trp182, Tyr183, and His184 were suitably overlapped with the
corresponding residues of cAC lyase, Trp126, Trp127, and His128,
and interacting with the sugar chain of a substrate chondroitin
[38]. Thus, this ODV-E66 model, shown in Fig. 3a, was concluded
to represent a model of active ODV-E66, with relative positions
of this model’s catalytic residues also conserved, as in other PL8
proteins exerting catalytic activity (Fig. 3b).
The present ODV-E66 model along with mutational analysis
indicated that the reaction mechanism of ODV-E66 was similar
to that of other PL8 lyases [31,38]. In the model, Asn236 and
His291 neutralized the carboxyl group of substrate glucuronic acid
and Tyr299 abstracted a proton, as a catalytic base at C-5 of glucu-
ronic acid (Fig. 4). At this stage, Arg345 interacted with O-4 binding
C-4 of glucuronic acid and assisted the role of Tyr299; Glu395 sup-
ported the reaction by interacting with His291 and Arg345. Then,
the glycosidic bond was broken, producing a new reducing end
and generating unsaturated sugar. Actually, in the active ODV-E66ltiple alignment of ODV-E66 with chondroitin lyases and/or hyaluronate lyases
ey active site residues; aligned lyases can degrade chondroitin sulfate A except for
hite on black, essential for catalysis for aligned lyases. The Arg or His, white on gray,
gure indicated as below: 1cb8, chondroitin AC lyase derived from Pedobacterium
ronate lyase derived from Streptomyces coelicolor A3(2); 1hn0, chondroitin ABC lyase
thetaiotaomicron WAL2926.
Fig. 3. Active ODV-E66 model with cAC lyase from P. heparinum. (A) The ODV-E66 model; orange, cAC lyase, blue; right ﬁgures enlarged active sites of left ﬁgure; and
substrate chondroitin in ﬁgure derived from ES complex structure of cAC lyase from P. heparinum. (B) The ODV-E66 model superposed on other PL8 enzymes based on
catalytic residues. Relative position of each catalytic residue shown; each protein’s pdb ID as in Fig. 2: 1cb8, blue; 1rw9, red; 2wda, pink; 1hn0, magenta; and 2q1f, cyan.
3946 Y. Kawaguchi et al. / FEBS Letters 587 (2013) 3943–3948model, the calculated pKa value of Tyr299 was decreased from 10.5
to 9.4 due to Arg345, calculated by MOE [39].
Using this active ODV-E66 model, a portion of ODV-E66’s un-
ique characters can be discussed. In terms of substrate speciﬁcity,
chondroitin lyases able to degrade chondroitin sulfate A have
either an Arg or His residue in their active sites (Fig. 2, gray and
Suppl. Fig. 3a). In cAC lyase from P. heparinum, the sulfate group
of chondroitin sulfate A is directly associated with Arg292 and,
interestingly, an R292A mutant of cAC exhibits low chondroitin
sulfate A activity [40]. In cABC lyase from Proteus vulgaris, thesulfate group of chondroitin sulfate A directly interacts with
His561 [41]. On the other hand, ODV-E66, which cannot degrade
chondroitin sulfate A, did not have these residues (Suppl. Fig. 3b)
and the nearest residue, Asn346 of ODV-E66, was far from the sul-
fate group of chondroitin sulfate A (6.6 Å). The absence of this key
residue appears to disallow ODV-E66 from degrading chondroitin
sulfate A.
Baculovirus host speciﬁcity and the stability of ODV-E66 could
also be discussed using this model. Comparing active ODV-E66
model with other PL8 enzymes, there were two structurally
Fig. 4. Schematic diagram indicating ODV-E66’s reaction mechanism. Five catalytic residues described around non-sulfated chondroitin disaccharide, and dashed line,
hydrogen bond network.
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(amino acid 350–365) as Suppl. Figs. 4 and 5. These regions might
contribute to the unique characters of baculovirus and ODV-E66.
First, host speciﬁcity of baculovirus might derive from Region 1.
Region 1 possesses sequences reported to interact with midgut
proteins in a host insect, Heliothis virescens [15] (Suppl. Fig. 4,
red and Suppl. Fig. 5). Thus, the unique conformation of this re-
gion might contribute to host speciﬁcity. Second, stability of
ODV-E66 might derive from Region 2 and a large number of
hydrophobic interactions in ODV-E66. Region 2 was an only loop
which was shorter than in other PL8 lyases (Suppl. Fig. 4). Region
2 consisted of 16 amino acids, while there are 63 amino acids on
average corresponding region in other PL8 enzymes (Suppl. Figs. 4
and 5). Because a solvent-exposed surface loop is known to be a
factor contributing to instability [42], the truncated loop of Re-
gion 2 might have correlated with high stability of ODV-E66. In
terms of hydrophobic interactions, a large number of aromatic-
aromatic interactions in ODV-E66 might have been the cause
for the observed stability; there were 55 aromatic-aromatic inter-
actions in ODV-E66, calculated by PCI server [43]. In contrast,
there are 34 such interactions in cAC lyase from P. heparinum,
28 in cAC lyase from A. aurescens, and 22 in hyaluronate lyase
from S. coelicolor A3(2), whose lyases lose their activity immedi-
ately in conditions over 50 C [9]. Therefore, this approximately
twofold greater number of interactions yields ODV-E66 structur-
ally rigid and stable.
In this study, the structural information of ODV-E66 was
found to partially explain the unique character of this enzyme.
As ODV-E66 is known as essential for oral infection by baculovi-
rus [14] and baculovirus has been widely used as a protein
expression system, our results will be helpful in the development
of more effective tools for protein expression. In addition, recent
studies have indicated that degrading chondroitin sulfate is use-
ful in the therapeutic ﬁeld, as an approach for treating spinal cord
injuries and intervertebral disc herniation [7,8], and the present
results might contribute to advancing research in this ﬁeld.
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